華納藥廠(688799.SH):擬中選廣東聯盟雙氯芬酸等藥品集中帶量採購
格隆匯3月11日丨華納藥廠(688799.SH)公佈,近日,湖南華納大藥廠股份有限公司參加了廣東聯盟雙氯芬酸等藥品集中帶量採購的投標。根據廣東省藥品交易中心2022年3月10日發佈的《關於公示廣東聯盟雙氯芬酸等藥品集中帶量採購(第一批)擬中選/備選結果的通知》顯示,公司蘭索拉唑腸溶片、小兒碳酸鈣D3顆粒、吸入用乙酰半胱氨酸溶液等產品擬中選本次集中帶量採購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.